Effective interventions and decline of antituberculosis drug resistance in Eastern Taiwan, 2004-2008

Yi Ting Chen, Jen Jyh Lee, Chen Yuan Chiang, Gee Gow Yang, Yeong Chu Tsai, Yeong Sheng Lee, Chih Bin Lin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: The Taiwan health authority recently launched several tuberculosis (TB) control interventions, which may have an impact on the epidemic of drug-resistant TB. We conducted a population-based antituberculosis drug resistance surveillance program in Eastern Taiwan to measure the proportions of notified TB patients with anti-TB drug resistance and the trend from 2004 to 2008. Methods and Findings: All culture-positive TB patients were enrolled. Drug susceptibility testing results of the first isolate of each TB patient in each treatment course were analyzed. In total, 2688 patients were included, of which 2176 (81.0%) were new TB cases and 512 (19.0%) were previously treated cases. Among the 2176 new TB cases, 97 (4.5%) were retreated after the first episode of TB treatment within the study period. The proportion of new patients with any resistance, isoniazid resistance but not multidrug-resistant TB (resistant to at least isoniazid and rifampin, MDR-TB), and MDR-TB was 16.4%, 7.5%, and 4.0%, respectively, and that among previously treated cases was 30.9%, 7.9%, and 17.6%, respectively. The combined proportion of any resistance decreased from 23.3% in 2004 to 14.3% in 2008, and that of MDR-TB from 11.5% to 2.4%. Conclusions: The proportion of TB patients with drug-resistant TB in Eastern Taiwan remains substantial. However, an effective TB control program has successfully driven the proportion of drug resistance among TB patients downward.

Original languageEnglish
Article numbere31531
JournalPLoS One
Volume7
Issue number2
DOIs
Publication statusPublished - Feb 23 2012

Fingerprint

drug resistance
Taiwan
Drug Resistance
tuberculosis
Tuberculosis
Multidrug-Resistant Tuberculosis
Pharmaceutical Preparations
Isoniazid
Rifampin
isoniazid
Health
drugs
Testing
rifampicin

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Effective interventions and decline of antituberculosis drug resistance in Eastern Taiwan, 2004-2008. / Chen, Yi Ting; Lee, Jen Jyh; Chiang, Chen Yuan; Yang, Gee Gow; Tsai, Yeong Chu; Lee, Yeong Sheng; Lin, Chih Bin.

In: PLoS One, Vol. 7, No. 2, e31531, 23.02.2012.

Research output: Contribution to journalArticle

Chen, Yi Ting ; Lee, Jen Jyh ; Chiang, Chen Yuan ; Yang, Gee Gow ; Tsai, Yeong Chu ; Lee, Yeong Sheng ; Lin, Chih Bin. / Effective interventions and decline of antituberculosis drug resistance in Eastern Taiwan, 2004-2008. In: PLoS One. 2012 ; Vol. 7, No. 2.
@article{48d4bc2e375547b5b3c7c8359cf4ebfe,
title = "Effective interventions and decline of antituberculosis drug resistance in Eastern Taiwan, 2004-2008",
abstract = "Background: The Taiwan health authority recently launched several tuberculosis (TB) control interventions, which may have an impact on the epidemic of drug-resistant TB. We conducted a population-based antituberculosis drug resistance surveillance program in Eastern Taiwan to measure the proportions of notified TB patients with anti-TB drug resistance and the trend from 2004 to 2008. Methods and Findings: All culture-positive TB patients were enrolled. Drug susceptibility testing results of the first isolate of each TB patient in each treatment course were analyzed. In total, 2688 patients were included, of which 2176 (81.0{\%}) were new TB cases and 512 (19.0{\%}) were previously treated cases. Among the 2176 new TB cases, 97 (4.5{\%}) were retreated after the first episode of TB treatment within the study period. The proportion of new patients with any resistance, isoniazid resistance but not multidrug-resistant TB (resistant to at least isoniazid and rifampin, MDR-TB), and MDR-TB was 16.4{\%}, 7.5{\%}, and 4.0{\%}, respectively, and that among previously treated cases was 30.9{\%}, 7.9{\%}, and 17.6{\%}, respectively. The combined proportion of any resistance decreased from 23.3{\%} in 2004 to 14.3{\%} in 2008, and that of MDR-TB from 11.5{\%} to 2.4{\%}. Conclusions: The proportion of TB patients with drug-resistant TB in Eastern Taiwan remains substantial. However, an effective TB control program has successfully driven the proportion of drug resistance among TB patients downward.",
author = "Chen, {Yi Ting} and Lee, {Jen Jyh} and Chiang, {Chen Yuan} and Yang, {Gee Gow} and Tsai, {Yeong Chu} and Lee, {Yeong Sheng} and Lin, {Chih Bin}",
year = "2012",
month = "2",
day = "23",
doi = "10.1371/journal.pone.0031531",
language = "English",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "2",

}

TY - JOUR

T1 - Effective interventions and decline of antituberculosis drug resistance in Eastern Taiwan, 2004-2008

AU - Chen, Yi Ting

AU - Lee, Jen Jyh

AU - Chiang, Chen Yuan

AU - Yang, Gee Gow

AU - Tsai, Yeong Chu

AU - Lee, Yeong Sheng

AU - Lin, Chih Bin

PY - 2012/2/23

Y1 - 2012/2/23

N2 - Background: The Taiwan health authority recently launched several tuberculosis (TB) control interventions, which may have an impact on the epidemic of drug-resistant TB. We conducted a population-based antituberculosis drug resistance surveillance program in Eastern Taiwan to measure the proportions of notified TB patients with anti-TB drug resistance and the trend from 2004 to 2008. Methods and Findings: All culture-positive TB patients were enrolled. Drug susceptibility testing results of the first isolate of each TB patient in each treatment course were analyzed. In total, 2688 patients were included, of which 2176 (81.0%) were new TB cases and 512 (19.0%) were previously treated cases. Among the 2176 new TB cases, 97 (4.5%) were retreated after the first episode of TB treatment within the study period. The proportion of new patients with any resistance, isoniazid resistance but not multidrug-resistant TB (resistant to at least isoniazid and rifampin, MDR-TB), and MDR-TB was 16.4%, 7.5%, and 4.0%, respectively, and that among previously treated cases was 30.9%, 7.9%, and 17.6%, respectively. The combined proportion of any resistance decreased from 23.3% in 2004 to 14.3% in 2008, and that of MDR-TB from 11.5% to 2.4%. Conclusions: The proportion of TB patients with drug-resistant TB in Eastern Taiwan remains substantial. However, an effective TB control program has successfully driven the proportion of drug resistance among TB patients downward.

AB - Background: The Taiwan health authority recently launched several tuberculosis (TB) control interventions, which may have an impact on the epidemic of drug-resistant TB. We conducted a population-based antituberculosis drug resistance surveillance program in Eastern Taiwan to measure the proportions of notified TB patients with anti-TB drug resistance and the trend from 2004 to 2008. Methods and Findings: All culture-positive TB patients were enrolled. Drug susceptibility testing results of the first isolate of each TB patient in each treatment course were analyzed. In total, 2688 patients were included, of which 2176 (81.0%) were new TB cases and 512 (19.0%) were previously treated cases. Among the 2176 new TB cases, 97 (4.5%) were retreated after the first episode of TB treatment within the study period. The proportion of new patients with any resistance, isoniazid resistance but not multidrug-resistant TB (resistant to at least isoniazid and rifampin, MDR-TB), and MDR-TB was 16.4%, 7.5%, and 4.0%, respectively, and that among previously treated cases was 30.9%, 7.9%, and 17.6%, respectively. The combined proportion of any resistance decreased from 23.3% in 2004 to 14.3% in 2008, and that of MDR-TB from 11.5% to 2.4%. Conclusions: The proportion of TB patients with drug-resistant TB in Eastern Taiwan remains substantial. However, an effective TB control program has successfully driven the proportion of drug resistance among TB patients downward.

UR - http://www.scopus.com/inward/record.url?scp=84863147000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863147000&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0031531

DO - 10.1371/journal.pone.0031531

M3 - Article

C2 - 22384034

AN - SCOPUS:84863147000

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 2

M1 - e31531

ER -